Second Heart Assist
Second Heart Assist, based in Salt Lake City, Utah, develops innovative circulatory assist devices, including the 'Whisper' catheter-based pump and 'Freedom' wireless implant, aimed at enhancing heart and renal function.
Company Overview
Second Heart Assist, headquartered in Salt Lake City, Utah, specializes in the development of catheter-based and wireless-powered chronic implant circulatory assist devices. Their innovative products aim to enhance both aortic wall motion and blood flow pulsatility. The company is presently conducting preclinical studies and planning clinical trials for FDA and CE Mark approval.
Products
Second Heart Assist develops two main products: 'Whisper' and 'Freedom'. 'Whisper' is a catheter-based pump designed to support circulatory functions, while 'Freedom' is a wireless-powered chronic implant. Both products are currently in early-stage development and have not yet been proven safe or effective. The company focuses on improving renal function and heart performance simultaneously with these devices.
Funding
Second Heart Assist has successfully raised over $15.4 million in funding through Series H financing. This significant investment supports the ongoing development and clinical preparations of their circulatory assist devices, demonstrating strong investor confidence in their technology and future potential.
Intellectual Property
Second Heart Assist holds a formidable intellectual property portfolio, including patents from leading cardiovascular physicians and CalTech. This extensive patent portfolio underpins the company's technological advances and provides a competitive edge in the MedTech innovation landscape.
Industry Recognition
In 2021, Second Heart Assist was featured in MedTech Outlook Magazine as a top MedTech innovation. This recognition highlights the company's commitment to advancing medical technology and underscores the potential impact of its circulatory assist devices on the healthcare industry.